CEO SUMMARY: All signs point to a potentially dismal financial outcome for the clinical lab testing industry as Congress tries to trim spending by $1.2 trillion over the next 10 years. At least three proposals to significantly cut lab test reimbursement are in active debate by federal lawmakers. One proposal calls for reinstituting the Medicare …
Congress Likely to Pass Deep Cuts in Lab Test Fees Read More »
To access this post, you must purchase The Dark Report.